We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Seeking Clues to Albemarle (ALB) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics
Read MoreHide Full Article
Analysts on Wall Street project that Albemarle (ALB - Free Report) will announce quarterly earnings of $1.24 per share in its forthcoming report, representing an increase of 788.9% year over year. Revenues are projected to reach $1.33 billion, increasing 23% from the same quarter last year.
Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted upward by 18.4% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.
That said, let's delve into the average estimates of some Albemarle metrics that Wall Street analysts commonly model and monitor.
The collective assessment of analysts points to an estimated 'Net Sales- Energy Storage' of $775.27 million. The estimate indicates a change of +47.8% from the prior-year quarter.
It is projected by analysts that the 'Net Sales- Specialties' will reach $319.07 million. The estimate points to a change of -0.6% from the year-ago quarter.
Based on the collective assessment of analysts, 'Net Sales- Ketjen' should arrive at $240.62 million. The estimate suggests a change of +4% year over year.
The combined assessment of analysts suggests that 'Adjusted EBITDA- Energy Storage' will likely reach $295.84 million. The estimate compares to the year-ago value of $186.36 million.
Analysts forecast 'Adjusted EBITDA- Specialties' to reach $55.13 million. The estimate compares to the year-ago value of $58.67 million.
Analysts' assessment points toward 'Adjusted EBITDA- Ketjen' reaching $33.15 million. The estimate is in contrast to the year-ago figure of $38.59 million.
Shares of Albemarle have demonstrated returns of +10.5% over the past month compared to the Zacks S&P 500 composite's +10.5% change. With a Zacks Rank #3 (Hold), ALB is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
Seeking Clues to Albemarle (ALB) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics
Analysts on Wall Street project that Albemarle (ALB - Free Report) will announce quarterly earnings of $1.24 per share in its forthcoming report, representing an increase of 788.9% year over year. Revenues are projected to reach $1.33 billion, increasing 23% from the same quarter last year.
Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted upward by 18.4% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.
That said, let's delve into the average estimates of some Albemarle metrics that Wall Street analysts commonly model and monitor.
The collective assessment of analysts points to an estimated 'Net Sales- Energy Storage' of $775.27 million. The estimate indicates a change of +47.8% from the prior-year quarter.
It is projected by analysts that the 'Net Sales- Specialties' will reach $319.07 million. The estimate points to a change of -0.6% from the year-ago quarter.
Based on the collective assessment of analysts, 'Net Sales- Ketjen' should arrive at $240.62 million. The estimate suggests a change of +4% year over year.
The combined assessment of analysts suggests that 'Adjusted EBITDA- Energy Storage' will likely reach $295.84 million. The estimate compares to the year-ago value of $186.36 million.
Analysts forecast 'Adjusted EBITDA- Specialties' to reach $55.13 million. The estimate compares to the year-ago value of $58.67 million.
Analysts' assessment points toward 'Adjusted EBITDA- Ketjen' reaching $33.15 million. The estimate is in contrast to the year-ago figure of $38.59 million.
View all Key Company Metrics for Albemarle here>>>Shares of Albemarle have demonstrated returns of +10.5% over the past month compared to the Zacks S&P 500 composite's +10.5% change. With a Zacks Rank #3 (Hold), ALB is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .